Insight
May 15, 2018
2018 Survey: Rollover and Incentive Equity Terms in Middle Market Private Equity
Related Content
- InsightNovember 19, 2026
The Changing Pharma Services Landscape: Partnerships, Growth, and Global Challenges
- AlertNovember 10, 2026
Delaware Court of Chancery Holds That “Transaction-Specific Control” Has No Place in Delaware’s Safe Harbor Statute
- InsightNovember 9, 2026
In Equity Rollovers, Which Rights Can Investors Expect?
- Alert6 November 2026
Clearance Is Not the Finish Line: KKR, NetCo, and the Regulator That Never Forgets
- Alert2 November 2026
Key Takeaways From the UK Budget 2026
- AlertOctober 28, 2026
FINRA Opens the Door to Projected Returns in Private Fund Marketing
- AlertOctober 27, 2026
SEC Proposes to Modernize Custody Rules, Including as to Crypto Assets
- NewslettersOctober 22, 2026
Debt Download
- Press ReleaseNovember 19, 2026
Goodwin Advises Frazier Healthcare Partners on Majority Investment in ATUM
- Press ReleaseNovember 19, 2026
Goodwin Advises IGEL on Strategic Investment From Vitruvian Partners
- Press ReleaseNovember 18, 2026
Goodwin Advises Omniose on Acquisition by AstraZeneca
- Press ReleaseNovember 18, 2026
Goodwin Advises JMI Equity on Its Investment in Blue J’s $176 Million Series E
- Press ReleaseNovember 16, 2026
Goodwin Advises Pharmakon on Intellectual Property Aspects of $150 Million Loan for CorMedix
- Press Release13 November 2026
Goodwin Advises neeyo on Refinancing
- Press ReleaseNovember 13, 2026
Goodwin Advises PERGAM on the Sale of Cem’In’Eu to Holcim
- Press ReleaseNovember 12, 2026
Goodwin Advises EOS Corrugated’s Sellers on Their Entry into Exclusive Negotiations with Five Arrows